Oncology – Targeted therapy Class

Showing 1 drugs

Selumetinib

Brand: Koselugo (global)
Class: Oncology – Targeted therapy
Subclass: MEK inhibitor
PK: t½ 7 hours | Clearance: hepatic
Max Dose: not added
moderate
AE: Diarrhea, acneiform rash, fatigue, cardiomyopathy risk (↓LVEF)